NVS Novartis AG Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

NVS [NYSE]

Novartis AG

Healthcare | Drug Manufacturers - General | Switzerland

statements

Index	-	P/E	26.60	EPS (ttm)	3.14	Insider Own	9.30%	Shs Outstand	2.29B	Perf Week	-1.17%
Market Cap	210.54B	Forward P/E	13.38	EPS next Y	6.24	Insider Trans	0.05%	Shs Float	2.26B	Perf Month	-4.99%
Income	7.21B	PEG	3.72	EPS next Q	1.43	Inst Own	10.90%	Short Float	0.09%	Perf Quarter	-2.26%
Sales	49.53B	P/S	4.25	EPS this Y	-43.60%	Inst Trans	0.06%	Short Ratio	1.15	Perf Half Y	-13.44%
Book/sh	23.51	P/B	3.55	EPS next Y	9.25%	ROA	6.00%	Target Price	101.00	Perf Year	-5.44%
Cash/sh	2.49	P/C	33.46	EPS next 5Y	7.15%	ROE	13.60%	52W Range	69.18 - 99.84	Perf YTD	-11.90%
Dividend	3.09	P/FCF	33.36	EPS past 5Y	-6.50%	ROI	8.60%	52W High	-16.45%	Beta	0.51
Dividend %	3.70%	Quick Ratio	0.60	Sales past 5Y	-1.90%	Gross Margin	71.00%	52W Low	20.58%	ATR	1.34
Employees	110000	Current Ratio	0.80	Sales Q/Q	-3.30%	Oper. Margin	18.70%	RSI (14)	41.73	Volatility	1.69% 1.38%
Optionable	Yes	Debt/Eq	0.65	EPS Q/Q	-10.30%	Profit Margin	14.60%	Rel Volume	0.61	Prev Close	84.15
Shortable	Yes	LT Debt/Eq	0.48	Earnings	Jul 21 BMO	Payout	89.50%	Avg Volume	1.74M	Price	83.42
Recom	1.00	SMA20	-2.80%	SMA50	-3.79%	SMA200	-5.54%	Volume	1,067,261	Change	-0.87%

Jun-15-20

Upgrade

Citigroup

Neutral → Buy

Mar-10-20

Upgrade

Morgan Stanley

Underweight → Equal-Weight

Feb-25-20

Downgrade

Guggenheim

Buy → Neutral

Apr-25-19

Upgrade

Liberum

Hold → Buy

Apr-25-19

Upgrade

Guggenheim

Neutral → Buy

Apr-10-19

Downgrade

Morgan Stanley

Equal-Weight → Underweight

Jan-02-19

Downgrade

JP Morgan

Neutral → Underweight

Dec-11-18

Resumed

Jefferies

Buy

Oct-09-18

Initiated

Guggenheim

Neutral

Sep-10-18

Upgrade

BofA/Merrill

Underperform → Buy

May-29-18

Downgrade

HSBC Securities

Buy → Hold

May-25-18

Upgrade

Credit Suisse

Underperform → Neutral

Jan-25-18

Reiterated

Leerink Partners

Outperform

$93 → $100

Dec-06-17

Downgrade

BofA/Merrill

Neutral → Underperform

Jul-26-17

Upgrade

Morgan Stanley

Underweight → Overweight

Jul-05-17

Downgrade

Credit Suisse

Neutral → Underperform

Mar-09-17

Initiated

Liberum

Buy

Mar-08-17

Upgrade

Societe Generale

Hold → Buy

Mar-07-17

Downgrade

Exane BNP Paribas

Neutral → Underperform

Jan-11-17

Downgrade

Credit Suisse

Outperform → Neutral

Aug-05-20 05:01PM	Novartis announces NEJM publication of Phase III ASCLEPIOS trials demonstrating superior efficacy of ofatumumab in patients with relapsing multiple sclerosis GlobeNewswire
Aug-04-20 04:11PM	Incyte Earnings Soar 65%, Easily Beating Views Investor's Business Daily
11:38AM	3 Stocks With Low Forward Price-Earnings Ratios GuruFocus.com
08:18AM	The Daily Biotech Pulse: Voyager, AbbVie End Collaboration, Thumbs Down For DBV's Peanut Allergy Patch, Tiziana Expedites COVID-19 Trial Plans Benzinga
01:15AM	Novartis announces Kymriah® meets primary endpoint at interim analysis of pivotal study in follicular lymphoma GlobeNewswire
Aug-03-20 04:07PM	Novartis Stock Lifted As Psoriasis Drug Notches EU Approval Investor's Business Daily
11:54AM	Novartis Stock Lifted As Psoriasis Drug Notches EU Approval Investor's Business Daily
Aug-02-20 04:31PM	The Market Continues to Undervalue AbbVie GuruFocus.com
Jul-31-20 03:41AM	China to add 56 drugs to price-slashing bulk-buy programme Reuters
Jul-30-20 06:43PM	7 Biopharmaceutical Companies Finding Success During COVID-19 CorpGov.com
Jul-28-20 11:40AM	Is a Beat in the Cards for Incyte's (INCY) Q2 Earnings? Zacks
09:26AM	The Zacks Analyst Blog Highlights: Facebook, Verizon Communications, Pfizer, Novartis and Philip Morris International Zacks
Jul-27-20 03:18PM	The Top 5 Trades of the Eaton Vance Worldwide Health Sciences Fund GuruFocus.com
01:24PM	Novartis Unveils 150M Antibiotics Investment For Europe TipRanks
Jul-24-20 02:06PM	5 High-Yield Drug Stocks That Are Undervalued With Great Upside InvestorPlace
10:27AM	Pharma Stock Roundup: NVS, RHHBY Earnings, AZN, PFE Coronavirus Vaccine Early Data Zacks
Jul-22-20 09:34AM	Company News for Jul 22, 2020 Zacks
04:01AM	Novartis (NVS) Q2 2020 Earnings Call Transcript Motley Fool
Jul-21-20 04:22PM	Novartis Stock Slips After Sales Miss Views On Coronavirus Impact Investor's Business Daily
12:40PM	What's Behind Novartis' Disappointing Q2 Results Motley Fool
12:23PM	The Dow Is Up Because Europe Is Spending $2.1 Trillion on a Recovery Plan Barrons.com
11:54AM	Biogen to study Spinraza in combination with $2 mln Novartis drug Reuters
09:54AM	Novartis' (NVS) Q2 Earnings Surpass Estimates, Sales Miss Zacks
09:39AM	Novartis Stock Falls as Swiss Drugmaker Cuts Sales Outlook on Pandemic Woes Barrons.com
09:00AM	Is Amgen Stock A Buy As It Takes A Dual Approach To Targeting Coronavirus? Investor's Business Daily
07:58AM	The Daily Biotech Pulse: Opko Wins CDC Contract, Novartis Lowers Guidance, Pieris Study Placed On Partial Clinical Hold Benzinga
05:16AM	Cocktails Boost Remy, Pandemic Disrupts Medicines: Earnings Wrap Bloomberg
04:00AM	Novartis CEO Narasimhan on Growth Prospects, Pandemic Disruption Bloomberg
01:30AM	Novartis trims sales outlook after hit from COVID disruptions Reuters
01:29AM	Novartis lowers sales outlook after second-quarter slip Reuters
01:00AM	Novartis delivered strong H1 performance. FY 2020 guidance confirmed at higher end for core operating income and lower end for sales. GlobeNewswire
Jul-16-20 08:31AM	The Daily Biotech Pulse: Mallinckrodt Gets FDA Panel Backing, Regulatory Setback For Tricida, Relay Therapeutics IPO Benzinga
07:28AM	Novartis To Sell Covid-19 Drugs At Zero-Profit To Low-Income Countries SmarterAnalyst
01:24AM	Novartis to provide 'no profit' COVID-19 drugs to low income countries Reuters
01:15AM	Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19 GlobeNewswire
Jul-15-20 10:05PM	Stocks - Europe Seen Lower Ahead of ECB Meeting Investing.com
09:00AM	Merck Is Now Pursuing Two Coronavirus Vaccines Is Merck Stock A Buy? Investor's Business Daily
07:21AM	Is Neoleukin Therapeutics a Buy? Motley Fool
Jul-14-20 06:42PM	New Products, Expanded Indications Drive Sales of Top 5 Pharmas GuruFocus.com
05:03PM	Why Rigel Pharmaceuticals Stock Skyrocketed 91% Today Motley Fool
Jul-13-20 06:33PM	Roche Forecasted to Be Top Drug Seller in 2026 GuruFocus.com
10:52AM	Did Hedge Funds Make The Right Call On Novartis AG (NVS) ? Insider Monkey
Jul-09-20 02:55PM	Regeneron Stock Is a Buy, Analyst Says. But She Isnt Counting on Its Covid-19 Antibody Cocktail. Barrons.com
Jul-07-20 10:25AM	Novartis Gets EC Approval for Enerzair Breezhaler for Asthma Zacks
09:52AM	The Zacks Analyst Blog Highlights: Novartis, Equinix, Newmont, Enterprise Products Partners and Franco-Nevada Zacks
08:17AM	The Daily Biotech Pulse: Novavax Lands $1.6B For COVID-19 Vaccine, Amgen Prevails In Avastin Biosimilar Lawsuit, Cellectis Study Placed On Clinical Hold Benzinga
07:58AM	Yates Class Action Law Encourages Long Term Stockholders of Novartis AG (NYSE: NVS) to Contact The Firm ACCESSWIRE
Jul-06-20 01:00PM	Top Analyst Reports for Novartis, Equinix & Newmont Zacks
11:33AM	6 Yield-Paying Stocks Trading at Cheap Prices GuruFocus.com
Jul-04-20 04:07PM	Notable Insider Buys: Novartis, T-Mobile And More Benzinga
Jul-02-20 11:00AM	Amgen Gets Favorable Appeals Court Ruling for Enbrel Patent Zacks
08:53AM	Novartis reaches $642m settlement with US authorities Financial Times
08:21AM	The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts Benzinga
06:04AM	Novartis pays $729 mln in U.S. kickback charges Reuters Videos
06:00AM	Novartis Settles $678M Fraud Lawsuit Alleging It Bribed Doctors At Company Speaker Events Benzinga
Jul-01-20 10:40PM	Novartis pays $729 million to settle U.S. kickback charges Reuters
10:08PM	Stocks - Europe Seen Higher on Virus Vaccine Optimism Investing.com
06:35PM	Novartis pays $729 million to settle U.S. kickback charges Reuters
03:47PM	Amgen's Win, Netflix's Hire Send Nasdaq Higher Motley Fool
10:42AM	Amgen patents on top-selling arthritis drug Enbrel upheld, shares rise Reuters
Jun-30-20 11:00AM	NVS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Novartis AG and Encourages Investors to Contact the Firm PR Newswire
Jun-29-20 04:34PM	Novartis Gets Positive CHMP View for Cosentyx Label Expansion Zacks
02:10PM	NVS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Novartis AG and Encourages Investors to Contact the Firm ACCESSWIRE
02:06PM	Race for a COVID-19 vaccine has drug makers scaling up manufacturing before one is developed MarketWatch
07:47AM	These 6 health-care stocks are buys because they can thrive under either Trump or Biden MarketWatch
Jun-28-20 11:36PM	Japan's Takeda expects $200 million operating loss related to Novartis' Xiidra withdrawal Reuters
02:23PM	The Week Ahead In Biotech (June 28- July 4): Pending Clinical Readouts In Focus During A Short Holiday Week Benzinga
Jun-26-20 07:32PM	EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Novartis AG NVS Business Wire
08:21AM	How gene therapy and CRISPR are helping to cure blindness MarketWatch
07:34AM	Novartis faces key meeting in U.S. bribery scandal after settling corruption case Reuters
07:23AM	Novartis faces key meeting in U.S. bribery scandal after settling corruption case Reuters
Jun-25-20 11:30PM	ESG strategies still buoyant despite Covid, say in-house lawyers Financial Times
03:57PM	Novartis Settles DoJ and SEC Charges for $347 Million TheStreet.com
03:49PM	Novartis, Units Admit Violating Bribery Law Bashed by Trump Bloomberg
02:49PM	UPDATE: Swiss drug company Novartis settles with DoJ, SEC in case brought under Foreign Corrupt Practices Act MarketWatch
01:31PM	Novartis, former unit to pay $346 million to resolve U.S. bribery charges Reuters
05:57AM	European stocks inch higher after previous days pounding; Wirecard collapses MarketWatch
Jun-22-20 02:51PM	Novartis Discontinues HCQ Study Due to Enrollment Challenges Zacks
Jun-19-20 06:04PM	Alzheimer's Drug Approval More Critical for Biogen After Patent Decision GuruFocus.com
04:32PM	Nkarta files for IPO MarketWatch
07:25AM	Pharma Stock Roundup: FDA Approvals to MRK, LLY, NVS and GSK's Drugs Zacks
Jun-18-20 05:53PM	PTC Announcement on Covid-19 Candidate Met With Investor Indifference GuruFocus.com
Jun-17-20 10:11AM	Lilly Stock Has a 10% Upside, Guggenheim Says Barrons.com
09:56AM	Novartis' (NVS) Cosentyx Gets FDA Nod for New Indication Zacks
07:30AM	The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked Benzinga
04:06AM	Novartis Scores FDA Ilaris Approval For Rare Type Of Arthritis SmarterAnalyst
Jun-16-20 10:49AM	Eli Lillys Cancer Drug Succeeded Where Pfizer Failed. What It Means for Their Stocks. Barrons.com
Jun-15-20 02:49PM	Coronavirus update: US sees steady resurgence as FDA puts nail in coffin of hydroxychloroquine debate Yahoo Finance
Jun-12-20 10:16AM	Do Hedge Funds Love Novartis AG (NVS)? Insider Monkey
Jun-11-20 03:23PM	Novartis' (NVS) Beovu Gets FDA Approval for Label Update Zacks
11:37AM	AstraZeneca's R&D Spending Spikes 21% to Industry Best in 2019 GuruFocus.com
Jun-10-20 01:04PM	U.S. attorney general group sues 26 dermatology drug makers Reuters
12:58PM	U.S. states accuse 26 drugmakers of generic drug price fixing in sweeping lawsuit Reuters
Jun-09-20 04:28PM	Roche, Johnson & Johnson Top R&D Spenders in 2019 GuruFocus.com
10:31AM	The Zacks Analyst Blog Highlights: Mastercard, Novartis, Boeing Company, Sanofi and Honeywell International Zacks
Jun-08-20 12:29PM	Vertex CEO Provided Best Value for Investors GuruFocus.com
10:59AM	Top Stock Reports for Mastercard, Novartis & Boeing Zacks
Jun-05-20 12:48PM	Hope dims for hydroxychloroquine even as medical study detailing the drugs failure is retracted MarketWatch
10:21AM	Novartis' Asthma Treatment Meets Primary Endpoint in Phase III Zacks
09:09AM	Pharma Stock Roundup: LLY Coronavirus Antibody Phase I Study Initiation, FDA Approvals Zacks

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. Its Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, cardio-metabolic, established, and cardiovascular, renal and metabolism medicine products. The company's Sandoz segment provides active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a range of therapeutic areas, as well as finished dosage form anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has collaboration agreements with Pear Therapeutics; Wyss Institute for Biologically Inspired Engineering at Harvard University and the Dana-Farber Cancer Institute; Science 37; Bill & Melinda Gates Foundation; Amgen; University of California, Berkeley; Bristol-Myers Squibb; Drugs for Neglected Diseases initiative (DNDi); TScan Therapeutics; and Dyno Therapeutics Inc. The company was founded in 1895 and is headquartered in Basel, Switzerland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novartis Bioventures Ltd	Former 10% Owner	Jun 30	Buy	17.00	125,000	2,125,000	1,181,258	Jul 02 04:16 PM
Novartis Bioventures Ltd	10% Owner	Nov 12	Buy	12.00	250,000	3,000,000	3,543,067	Nov 12 04:15 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience